(Q40867501)

24 September 2017

title

Reduced growth rate accompanied by aberrant epidermal growth factor signaling in drug resistant human breast cancer cells (English)

1 reference

24 September 2017

K Wosikowski

1

1 reference

24 September 2017

J A Silverman

2

1 reference

24 September 2017

P Bishop

3

1 reference

24 September 2017

J Mendelsohn

4

1 reference

24 September 2017

S E Bates

5

1 reference

24 September 2017

publication date

1 July 2000

1 reference

Biochimica et Biophysica Acta

24 September 2017

published in

1 reference

24 September 2017

volume

1497

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

215-226

1 reference

In vitro effect of doxorubicin on non-proliferating and proliferating epithelial cells

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Retinoblastoma (RB1) gene product expression in breast carcinoma. Correlation with Ki-67 growth fraction and biopathological profile

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Predictive value of EGF receptor in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Selective changes in EGF receptor expression and function during the proliferation, differentiation and apoptosis of mammary epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Cellular survival: a play in three Akts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Increased epidermal growth factor receptor in an estrogen-responsive, adriamycin-resistant MCF-7 cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Increased resistance to cytotoxic agents in ZR75B human breast cancer cells transfected with epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Enhancement of drug sensitivity of human malignancies by epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

The role of reduced growth rate in the development of drug resistance of HOB1 lymphoma cells to vincristine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Increased epidermal growth factor receptor in multidrug-resistant human neuroblastoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Differential signal transduction of epidermal-growth-factor receptors in hormone-dependent and hormone-independent human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Epidermal growth factor-related peptides in the pathogenesis of human breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Non-P-glycoprotein-mediated multidrug resistance with reduced EGF receptor expression in a human large cell lung cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Growth factors, apoptosis, and survival of mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

The MAPK signaling cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Epidermal growth factor as an autocrine modulator of stress response in mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Altered expression of epidermal growth factor receptor gene in a classical multidrug-resistant variant of a human cancer cell line, KB.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

The stress-activated protein kinase pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Regulation of transcription by MAP kinase cascades

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

Phosphorylation and regulation of Raf by Akt (protein kinase B)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2800%2900062-8

7 January 2021

10.1016/S0167-4889(00)00062-8

Identifiers

DOI

1 reference

release_y24zbvfwxffvfp4qnt3p3eqbcu

24 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/y24zbvfwxffvfp4qnt3p3eqbcu

24 November 2022

mapped directly with Wikidata item

1 reference